• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Chinook Therapeutics, Inc. - Common Stock (NQ: KDNY )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, Aug 10, 2023 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Chinook Therapeutics, Inc. - Common Stock

    < Previous 1 2 3 Next >
    Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
    Via Benzinga
    Expert Ratings for Chinook Therapeutics
    Via Benzinga
    What 6 Analyst Ratings Have To Say About Chinook Therapeutics
    Via Benzinga
    What To Know About Guggenheim's Downgrade of Chinook Therapeutics
    Via Benzinga
    Health Care Company Novartis Announces Merger With Chinook Therapeutics
    Via Benzinga
    Meet Chinook Therapeutics, The Company Novartis Is Spending $3.5 Billion To Acquire
    Chinook Therapeutics has a history of being opportunistic. Now, it's joining forces with Novartis. 
    Via Investor's Business Daily
    Why Shares of Vera Therapeutics Jumped Tuesday
    The company announced early phase 2 trials information regarding its lead therapy. 
    Via The Motley Fool
    2 Surging Healthcare Stocks With More Fuel in the Tank
    These stocks climbed 74% and 78% over the past month and there could be more gains ahead. 
    Via The Motley Fool
    Stock Market Rally Runs Through Hawkish Fed; Adobe, Lennar, Oracle, UnitedHealth In Focus: Weekly Review
    Stocks kept powering higher despite, but the Nasdaq is looking extended. 
    Via Investor's Business Daily
    Benzinga's Top Ratings Upgrades, Downgrades For June 13, 2023
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For June 14, 2023
    Via Benzinga
    KDNY Stock Alert: Why Short Seller Muddy Waters Is Betting Against Chinook
    Chinook Therapeutics is about to be acquired by Novartis. News of this deal hasn't stopped Muddy Waters from betting against KDNY stock. 
    Via InvestorPlace
    Nasdaq Gains 1%; US Budget Deficit Widens In May
    U.S. stocks traded higher toward the end of trading, with Nasdaq Composite gaining over 100 points on Monday. The Dow traded up 0.19% to 33,939.74 while the NASDAQ rose 1% to 13,391.54. The S&P 500,... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    Stocks Sport Midday Leads As Busy Week Begins
    Stocks are modestly higher this afternoon amid hopes of a dovish Fed, with the central bank's policy decision due out Wednesday. 
    Via Talk Markets
    Why Asset Entities Shares Are Trading Higher By 142%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Gainers Asset Entities Inc. (NASDAQ: ASST) shares jumped 142% to $2.79 after the company announced the development of an AI bot as part of its AE360DDM suite of services on Discord. 
    Via Benzinga
    Why Shares of Chinook Therapeutics Skyrocketed On Monday
    The company, which specializes in treating kidney diseases, agreed to a buyout offer. 
    Via The Motley Fool
    Crude Oil Drops Sharply; Chinook Therapeutics Shares Spike Higher
    U.S. stocks traded higher midway through trading, with Dow Jones gaining over 40 points on Monday. The Dow traded up 0.12% to 33,919.07 while the NASDAQ rose 0.49% to 13,323.71. The S&P 500, also rose,... 
    Via Benzinga
    Chinook Therapeutics Launches Almost 60% On Novartis' $3.5 Billion Takeover
    Novartis will pay $3.5 billion to buy the kidney disease-focused biotech company. 
    Via Investor's Business Daily
    XPeng's New EV Is a Hit, but This Biotech Stock Is Leaving It in the Dust
    Find out more about two big winners Monday morning. 
    Via The Motley Fool
    US Stocks Open Higher; Nasdaq Rises Over 50 Points
    U.S. stocks traded higher this morning, with Nasdaq Composite gaining over 50 points on Monday. Following the market opening Monday, the Dow traded up 0.21% to 33,948.78 while the NASDAQ rose 0.47% to... 
    Via Benzinga
    Broadcom Might Receive European Approval For $61B VMware Deal, UBS Closes Credit Suisse Takeover, Illumina CEO Steps Down Amid Activist Investor Carl Icahn's Pressure: Today's Top Stories
    Reuters Broadcom Most Likely To Receive EU Approval For $61B VMware Merger 
    Via Benzinga
    Why Is Oncorus (ONCR) Stock Down 27% Today?
    Oncorus (ONCR) stock is taking a beating on Monday after revealing plans for a vote during an upcoming special shareholder meeting. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    Why Is Chinook Therapeutics (KDNY) Stock Up 58% Today?
    Chinook Therapeutics (KDNY) stock is rocketing higher on Monday after the company announced it's being acquired by Novartis AG (NVS). 
    Via InvestorPlace
    Why Oncorus Shares Are Trading Lower By 25%; Here Are 20 Stocks Moving Premarket
    Gainers Auddia Inc. (NASDAQ: AUUD) shares rose 103.2% to $0.8809 in pre-market trading after gaining around 9% on Friday. 
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
    We're starting off the week with a breakdown of the biggest pre-market stock movers traders need to know about for Monday morning! 
    Via InvestorPlace
    Why Are Chinook Therapeutics Shares Trading Higher Today
    Novartis AG (NYSE: NVS) has agreed to acquire Chinook Therapeutics Inc (NASDAQ: KDNY) for $40 per share in cash,  
    Via Benzinga
    Nasdaq, S&amp;P 500 Futures Signal Strong Start To Week On Hopes Of Fed Pause: Why This Analyst Is Pricing In A 20% Gain From Bear Market Low
    Via Benzinga
    < Previous 1 2 3 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.